期刊文献+

硫酸氢氯吡格雷有关物质的合成及工艺应用 被引量:2

Synthesis of Related Substances of Clopidogrel Bisulfate and the Innovation of Synthesis Process
下载PDF
导出
摘要 硫酸氢氯吡格雷是一种通过抑制血小板聚集高效的抗血栓药物,临床上主要用于治疗动脉粥样硬化引起的心脏病或中风。有关物质的研究是药品质量研究中关键性项目之一,其含量是评价药品的纯度是否合格的重要指标。结合硫酸氢氯吡格雷成熟合成路线,分析了3个潜在的硫酸氢氯吡格雷的有关物质,并利用硫酸氢氯吡格雷合成过程所用到的原料、中间体或成品进行了合成制备,通过1 H NMR、13C NMR、HRMS对产物的结构进行表征与确证。结合3个有关物质的监测结果,对硫酸氢氯吡格雷的进一步工艺优化提出建议。 Clopidogrel bisulfate is a highly effective antithrombotic drug that inhibits platelet aggregation.It is clinically used to treat heart disease or stroke caused by atherosclerosis.The research of related substances is the key item in the research of drug quality,and it is an important index to evaluate whether the purity of the drug is qualified.Combined with the synthesis route of clopidogrel bisulfate,three potential related substances of clopidogrel bisulfate were analyzed and prepared from the raw materials,intermediates or finished products used in the synthesis process of clopidogrel bisulfate.The structures of three related substances were characterized by 1 H NMR,13C NMR and HRMS.Combined with the monitoring results of three related substances,the process improvement for the synthesis of clopidogrel bisulfate was proposed.
作者 刘良辉 李昕颖 胡昱 LIU Liang-hui;LI Xin-ying;HU Yu(School of Chemistry,Nanchang University,Nanchang 330036,China)
出处 《精细化工中间体》 CAS 2021年第5期43-47,69,共6页 Fine Chemical Intermediates
关键词 硫酸氢氯吡格雷 有关物质 合成方法 clopidogrel bisulfate related substances synthetic methods
  • 相关文献

参考文献2

二级参考文献26

  • 1CURE Study Investigators.The Clopidogrel in unstable angina to prevent recurrent events (CURE) trial programme ; rationale,design and baseline characteristics including a metaanalysis of the effects of thienopyridines in vascular disease[J].Eur Heart J,2000,21(24):2033-2041.
  • 2Sabatine MS,Cannon CP,Gibson CM,et al.Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation[J].N Eng J Med,2005,352(12):1179-1189.
  • 3Umesh NK,Steven EN.Is CURE a cure for acute coronary syndromes?statistical versus clinical significance[J].JACC,2002,40(2):218-219.
  • 4Steinhubl SR,Berger PB,Mann III JT,et al.Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention:a randomized controlled trial[J].JAMA,2002,288(19):2411-2420.
  • 5Harrington RA,Becker RC,Ezekowitz M,et al.Antithrombotic therapy for coronary artery disease:the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy[J].Chest,2004,126(3 suppl):513S-548S.
  • 6Bertrand ME,Rupprecht HJ,Urban P,et al.Double-Blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting:the clopidogrel aspirin stent international cooperative study (CLASSICS)[J].Circulation,2000,102(6):624-629.
  • 7Kandzari DE,Berger PB,Kastrati A,et al.Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization[J].J Am Coll Cardiol,2004,44(11):2133-2136.
  • 8Adnan K,Nicolas VB,Alexander J,et al.Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy[J].Circulation,2004,110(14):1916-1919.
  • 9Bates ER,Lau WC,Bleske BE.Loading,pretreatment,and interindividual variability issues with clopidogrel dosing[J].Circulation,2005,111(20):2557-2559.
  • 10Muller I,Seyfarth M,Rudiger S,et al.Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement[J].HEART,2001,85(1):92-93.

共引文献87

同被引文献18

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部